Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
J Lipid Res ; 57(10): 1854-1864, 2016 10.
Artículo en Inglés | MEDLINE | ID: mdl-27527703

RESUMEN

Thraustochytrium, a unicellular marine protist, has been used as a commercial source of very long chain PUFAs (VLCPUFAs) such as DHA (22:6n-3). Our recent work indicates coexistence of a Δ4-desaturation-dependent pathway (aerobic) and a polyketide synthase-like PUFA synthase pathway (anaerobic) to synthesize the fatty acids in Thraustochytrium sp. 26185. Heterologous expression of the Thraustochytrium PUFA synthase along with a phosphopantetheinyl transferase in Escherichia coli showed the anaerobic pathway was highly active in the biosynthesis of VLCPUFAs. The amount of Δ4 desaturated VLCPUFAs produced reached about 18% of the total fatty acids in the transformant cells at day 6 in a time course of the induced expression. In Thraustochytrium, the expression level of the PUFA synthase gene was much higher than that of the Δ4 desaturase gene, and also highly correlated with the production of VLCPUFAs. On the other hand, Δ9 and Δ12 desaturations in the aerobic pathway were either ineffective or absent in the species, as evidenced by the genomic survey, heterologous expression of candidate genes, and in vivo feeding experiments. These results indicate that the anaerobic pathway is solely responsible for the biosynthesis for VLCPUFAs in Thraustochytrium.


Asunto(s)
Ácido Graso Desaturasas , Acido Graso Sintasa Tipo II , Ácidos Grasos Insaturados/biosíntesis , Estramenopilos , Anaerobiosis/fisiología , Ácido Graso Desaturasas/biosíntesis , Ácido Graso Desaturasas/genética , Acido Graso Sintasa Tipo II/biosíntesis , Acido Graso Sintasa Tipo II/genética , Estramenopilos/genética , Estramenopilos/metabolismo
2.
Food Funct ; 7(5): 2420-30, 2016 May 18.
Artículo en Inglés | MEDLINE | ID: mdl-27157892

RESUMEN

Dietary supplementation of soy stachyose or genistein is known to be of hepatoprotective health interest. This study showed that co-administration of genistein and stachyose caused stronger inhibition on abnormal weight gain and liver fat accumulation by decreasing fatty acid synthetase expression and balancing disorderly lipid metabolism than that of genistein or stachyose alone in high-fructose (HF) diet-fed mice. Furthermore, the production of malonaldehyde and carbonyl derivatives of proteins was also more effectively inhibited by co-treatment of genistein and stachyose, and thereby glutathione peroxidase and superoxide dismutase activities were elevated in HF-fed mice. Moreover, genistein in combination with stachyose was more effective to reduce the impact of HF on the serum markers of liver damage by inhibiting inflammatory cytokine release than stachyose or genistein alone in mice. The potential mechanism was that stachyose enhanced absorption of genistein in HF-fed mice by oral supplementation of genistein together with stachyose. These findings indicate that co-ingestion of stachyose and genistein may serve as a novel strategy for hepatic protection.


Asunto(s)
Administración Oral , Carbohidratos de la Dieta/efectos adversos , Fructosa/efectos adversos , Genisteína/farmacología , Hígado/efectos de los fármacos , Oligosacáridos/farmacología , Sustancias Protectoras/farmacología , Tejido Adiposo/efectos de los fármacos , Animales , Biomarcadores/sangre , Análisis Químico de la Sangre , Peso Corporal/efectos de los fármacos , Citocinas/metabolismo , Carbohidratos de la Dieta/administración & dosificación , Combinación de Medicamentos , Acido Graso Sintasa Tipo II/biosíntesis , Acido Graso Sintasa Tipo II/efectos de los fármacos , Ácidos Grasos/sangre , Hígado Graso/prevención & control , Heces/química , Genisteína/administración & dosificación , Glutatión Peroxidasa/efectos de los fármacos , Homeostasis/efectos de los fármacos , Inflamación , Resistencia a la Insulina , Absorción Intestinal/efectos de los fármacos , Metabolismo de los Lípidos/efectos de los fármacos , Hígado/química , Hígado/lesiones , Hígado/patología , Masculino , Malondialdehído/metabolismo , Ratones , Estrés Oxidativo/efectos de los fármacos , Sustancias Protectoras/administración & dosificación , Glycine max/química , Superóxido Dismutasa/efectos de los fármacos , Orina/química , Aumento de Peso/efectos de los fármacos
3.
World J Microbiol Biotechnol ; 32(6): 102, 2016 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-27116968

RESUMEN

Pinosylvin as a bioactive stilbene is of great interest for food supplements and pharmaceuticals development. In comparison to conventional extraction of pinosylvin from plant sources, biosynthesis engineering of microbial cell factories is a sustainable and flexible alternative method. Current synthetic strategies often require expensive phenylpropanoic precursor and inducer, which are not available for large-scale fermentation process. In this study, three bioengineering strategies were described to the development of a simple and economical process for pinosylvin biosynthesis in Escherichia coli. Firstly, we evaluated different construct environments to give a highly efficient constitutive system for enzymes of pinosylvin pathway expression: 4-coumarate: coenzyme A ligase (4CL) and stilbene synthase (STS). Secondly, malonyl coenzyme A (malonyl-CoA) is a key precursor of pinosylvin bioproduction and at low level in E. coli cell. Thus clustered regularly interspaced short palindromic repeats interference (CRISPRi) was explored to inactivate malonyl-CoA consumption pathway to increase its availability. The resulting pinosylvin content in engineered E. coli was obtained a 1.9-fold increase depending on the repression of fabD (encoding malonyl-CoA-ACP transacylase) gene. Eventually, a phenylalanine over-producing E. coli consisting phenylalanine ammonia lyase was introduced to produce the precursor of pinosylvin, trans-cinnamic acid, the crude extraction of cultural medium was used as supplementation for pinosylvin bioproduction. Using these combinatorial processes, 47.49 mg/L pinosylvin was produced from glycerol.


Asunto(s)
Bioingeniería/métodos , Proteínas de Escherichia coli/genética , Proteínas de Escherichia coli/metabolismo , Escherichia coli/genética , Escherichia coli/metabolismo , Estilbenos/metabolismo , S-Maloniltransferasa de la Proteína Transportadora de Grupos Acilo/biosíntesis , S-Maloniltransferasa de la Proteína Transportadora de Grupos Acilo/genética , Aciltransferasas/metabolismo , Cinamatos/química , Coenzima A Ligasas/metabolismo , Ácidos Cumáricos/metabolismo , Escherichia coli/enzimología , Proteínas de Escherichia coli/biosíntesis , Proteínas de Escherichia coli/química , Acido Graso Sintasa Tipo II/biosíntesis , Acido Graso Sintasa Tipo II/genética , Ácidos Grasos/biosíntesis , Glicerol/metabolismo , Malonil Coenzima A/metabolismo , Fenilalanina/metabolismo , Estilbenos/química , Estilbenos/economía
4.
Metab Eng ; 29: 217-226, 2015 May.
Artículo en Inglés | MEDLINE | ID: mdl-25863265

RESUMEN

Malonyl-CoA is the building block for fatty acid biosynthesis and also a precursor to various pharmaceutically and industrially valuable molecules, such as polyketides and biopolymers. However, intracellular malonyl-CoA is usually maintained at low levels, which poses great challenges to efficient microbial production of malonyl-CoA derived molecules. Inactivation of the malonyl-CoA consumption pathway to increase its intracellular availability is not applicable, since it is usually lethal to microorganisms. In this work, we employ synthetic antisense RNAs (asRNAs) to conditionally down-regulate fatty acid biosynthesis and achieve malonyl-CoA enrichment in Escherichia coli. The optimized asRNA constructs with a loop-stem structure exhibit high interference efficiency up to 80%, leading to a 4.5-fold increase in intracellular malonyl-CoA concentration when fabD gene expression is inhibited. Strikingly, this strategy allows the improved production of natural products 4-hydroxycoumarin, resveratrol, and naringenin by 2.53-, 1.70-, and 1.53-fold in E. coli, respectively. In addition, down-regulation of other fab genes including fabH, fabB, and fabF also leads to remarkable increases in 4-hydroxycoumarin production. This study demonstrates a novel strategy to enhance intracellular malonyl-CoA and indicates the effectiveness of asRNA as a powerful tool for use in metabolic engineering.


Asunto(s)
S-Maloniltransferasa de la Proteína Transportadora de Grupos Acilo/biosíntesis , Proteínas de Escherichia coli/biosíntesis , Regulación Bacteriana de la Expresión Génica , Regulación Enzimológica de la Expresión Génica , Malonil Coenzima A , ARN sin Sentido , Acido Graso Sintasa Tipo II/biosíntesis , Malonil Coenzima A/genética , Malonil Coenzima A/metabolismo , ARN sin Sentido/biosíntesis , ARN sin Sentido/genética
5.
Appl Biochem Biotechnol ; 168(5): 980-90, 2012 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-22899014

RESUMEN

The extraction and determination of alkaloids was performed and confirmed by phytochemical analysis. Six different quinazoline alkaloids (vasicoline, vasicolinone, vasicinone, vasicine, adhatodine and anisotine) were found in the leaf of Justicia adhatoda (J. adhatoda). The presence of the peaks obtained through HPLC indicated the diverse nature of alkaloid present in the leaf. The enzyme ß-ketoacyl-acyl-carrier protein synthase III that catalyses the initial step of fatty acid biosynthesis (FabH) via a type II fatty acid synthase has unique structural features and universal occurrence in Mycobacterium tuberculosis (M. tuberculosis). Thus, it was considered as a target for designing of anti-tuberculosis compounds. Docking simulations were conducted on the above alkaloids derived from J. adhatoda. The combination of docking/scoring provided interesting insights into the binding of different inhibitors and their activity. These results will be useful for designing inhibitors for M. tuberculosis and also will be a good starting point for natural plant-based pharmaceutical chemistry.


Asunto(s)
Alcaloides , Antituberculosos , Género Justicia/química , Pirroles , Quinazolinas , 3-Oxoacil-(Proteína Transportadora de Acil) Sintasa , Alcaloides/química , Alcaloides/aislamiento & purificación , Alcaloides/farmacología , Antituberculosos/química , Antituberculosos/aislamiento & purificación , Antituberculosos/farmacología , Biología Computacional/métodos , Acido Graso Sintasa Tipo II/biosíntesis , Humanos , Simulación del Acoplamiento Molecular , Mycobacterium tuberculosis/efectos de los fármacos , Hojas de la Planta/química , Pirroles/química , Pirroles/aislamiento & purificación , Pirroles/farmacología , Quinazolinas/química , Quinazolinas/aislamiento & purificación , Quinazolinas/farmacología , Tuberculosis
6.
Traffic ; 10(10): 1471-80, 2009 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-19602198

RESUMEN

Toxoplasma gondii is an obligate intracellular parasite from the phylum Apicomplexa. A hallmark of these protozoans is the presence of a unique apical complex of organelles that includes the apicoplast, a plastid acquired by secondary endosymbiosis. The apicoplast is indispensible for parasite viability. It harbours a fatty acid biosynthesis type II (FAS II) pathway and plays a key role in the parasite lipid metabolism. Possibly, the apicoplast provides components for the establishment and the maturation of the parasitophorous vacuole, ensuring the successful infection of the host cell. This implies the presence of a transport mechanism for fast and accurate allocation of lipids between the apicoplast and other membrane-bound compartments in the parasite cell. Using a combination of high-pressure freezing, freeze-substitution and electron tomography, we analysed the ultrastructural organization of the apicoplast of T. gondii in relation with the endoplasmic reticulum (ER). This allowed us to clearly show the presence of four continuous membranes surrounding the apicoplast. We present, for the first time, the existence of membrane contact sites between the apicoplast outermost membrane and the ER. We describe the morphological characteristics of these structures and discuss their potential significance for the subcellular distribution of lipids in the parasite.


Asunto(s)
Retículo Endoplásmico/ultraestructura , Acido Graso Sintasa Tipo II/biosíntesis , Interacciones Huésped-Parásitos , Membranas Intracelulares/ultraestructura , Orgánulos/ultraestructura , Toxoplasma/ultraestructura , Animales , Transporte Biológico , Chlorocebus aethiops , Crioultramicrotomía , Tomografía con Microscopio Electrónico , Retículo Endoplásmico/metabolismo , Retículo Endoplásmico/parasitología , Ácidos Grasos/biosíntesis , Membranas Intracelulares/metabolismo , Metabolismo de los Lípidos , Modelos Biológicos , Orgánulos/metabolismo , Simbiosis/fisiología , Toxoplasma/enzimología , Toxoplasma/metabolismo , Vacuolas/metabolismo , Vacuolas/parasitología , Vacuolas/ultraestructura , Células Vero
7.
J Am Chem Soc ; 130(20): 6336-7, 2008 May 21.
Artículo en Inglés | MEDLINE | ID: mdl-18444614

RESUMEN

Acyl carrier protein (ACP) plays an essential role in fatty acid and polyketide biosynthesis, and most of the fatty acid synthases (FASs) and polyketide synthases (PKSs) known to date are characterized with a single ACP for each cycle of chain elongation. Polyunsaturated fatty acid (PUFA) biosynthesis is catalyzed by the PUFA synthase, and all PUFA synthases known to date contain tandem ACPs (ranging from 5 to 9). Using the Pfa PUFA synthase from Shewanella japonica as a model system, we report here that these tandem ACPs are functionally equivalent regardless of their physical location within the PUFA synthase subunit, but the total number of ACPs controls the overall PUFA titer. These findings set the stage to interrogate other domains and subunits of PUFA synthase for their roles in controlling the final PUFA products and could potentially be exploited to improve PUFA production.


Asunto(s)
Proteína Transportadora de Acilo/metabolismo , Ácidos Grasos Insaturados/biosíntesis , Ácidos Docosahexaenoicos/metabolismo , Ácido Eicosapentaenoico/biosíntesis , Escherichia coli/enzimología , Escherichia coli/genética , Acido Graso Sintasa Tipo II/biosíntesis , Acido Graso Sintasa Tipo II/genética , Acido Graso Sintasa Tipo II/metabolismo , Estructura Terciaria de Proteína , Proteínas Recombinantes/biosíntesis , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Shewanella/enzimología , Shewanella/genética , Shewanella/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA